Quality of Life and Late Effects Following Haploidentical vs. Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation: Secondary Analysis of BMT CTN 1702.

Farhadfar N; He N; Logan B; Horowitz MM; Dehn JG; Pidala J; Grunwald MR; Westervelt P; Hogan WJ; Bashey A; Hayes-Lattin B; Hill L; Brunstein C; Arai S; Srour SA; Symons H; Uberti J; Vasu S; Pusic I; Juckett M; Leifer E; Devine S; Ciurea SO; Lee SJ; Shaw BE

doi:10.1016/j.jtct.2026.10.043

SCHEDA SCIENTIFICA2026Altra ricerca

Quality of Life and Late Effects Following Haploidentical vs. Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation: Secondary Analysis of BMT CTN 1702.

Farhadfar N, He N, Logan B, Horowitz MM, Dehn JG, Pidala J, Grunwald MR, Westervelt P, Hogan WJ, Bashey A, Hayes-Lattin B, Hill L, Brunstein C, Arai S, Srour SA, Symons H, Uberti J, Vasu S, Pusic I, Juckett M, Leifer E, Devine S, Ciurea SO, Lee SJ, Shaw BE

Transplantation and cellular therapy · 2026

Psicologia clinica Psicologia della salute

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Come citare questo studio

Farhadfar N, He N, Logan B, Horowitz MM, Dehn JG, Pidala J, Grunwald MR, Westervelt P, Hogan WJ, Bashey A, Hayes-Lattin B, Hill L, Brunstein C, Arai S, Srour SA, Symons H, Uberti J, Vasu S, Pusic I, Juckett M, Leifer E, Devine S, Ciurea SO, Lee SJ, Shaw BE. (2026). Quality of Life and Late Effects Following Haploidentical vs. Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation: Secondary Analysis of BMT CTN 1702.. Transplantation and cellular therapy. DOI: 10.1016/j.jtct.2026.10.043

Consulta la pubblicazione originale ↗